Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.4.2.3 Other antivirals for hepatitis C |
Outras observações: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines. |
WHO Model List of Essential Medicines (2021) | 6.4.3. Other antivirals |
Outras observações: For the treatment of viral haemorrhagic fevers. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.4.2.3 Other antivirals for hepatitis C |
Outras observações: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines. |
WHO Model List of Essential Medicines (2021) | 6.4.3. Other antivirals |
Outras observações: For the treatment of viral haemorrhagic fevers. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.4.2.3 Other antivirals for hepatitis C |
Outras observações: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines. |
WHO Model List of Essential Medicines (2021) | 6.4.3. Other antivirals |
Outras observações: For the treatment of viral haemorrhagic only. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.4.2.3 Other antivirals for hepatitis C |
Outras observações: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines |
WHO Model List of Essential Medicines (2021) | 6.4.3. Other antivirals |
Outras observações: For the treatment of viral haemorrhagic fevers. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.3. Other antivirals |
Outras observações: For the treatment of viral haemorrhagic fevers. |
WHO Model List of Essential Medicines (2021) | 6.4.4.2.3 Other antivirals for hepatitis C |
Outras observações: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines. |
Listas | Seção | Observação |
---|---|---|
Cuba | 6.4 Antivirales | Sem observações |